(Q32077110)

6 July 2017

1 reference

title

Nicotine and its interaction with beta-amyloid protein: a short review (English)

1 reference

6 July 2017

0 references

Zamani MR

1

1 reference

PubMed ID

11230873

6 July 2017

Allen YS

series ordinal

2

1 reference

PubMed ID

11230873

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

6 July 2017

Biological Psychiatry

1 reference

6 July 2017

49

1 reference

6 July 2017

3

1 reference

6 July 2017

221-232

1 reference

Lack of desensitization of muscarinic receptor-mediated second messenger signals in rat brain upon acute and chronic inhibition of acetylcholinesterase.

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Characterization of N-[3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

beta-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

The ability of amyloid beta-protein [A beta P (1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Developmental expression of alpha 7 neuronal nicotinic receptor messenger RNA in rat sensory cortex and thalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

beta-Amyloid (25-35) or substance P stimulates [3H]MK-801 binding to rat cortical membranes in the presence of glutamate and glycine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

An amyloid peptide, beta A4 25-35, mimics the function of substance P on modulation of nicotine-evoked secretion and desensitization in cultured bovine adrenal chromaffin cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Role of potassium channels in amyloid-induced cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Effects of beta-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Amyloid beta-peptide (A beta P) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Selective loss of central cholinergic neurons in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Calcium permeability of the nicotinic acetylcholine receptor: the single-channel calcium influx is significant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Tacrine in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Inhibition of nicotine-induced hippocampal norepinephrine release in rats by alpha-conotoxins MII and AuIB microinjected into the locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Hippocampal synaptic transmission enhanced by low concentrations of nicotine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--I. Amelioration of cognitive deficits by transplants into cortex and hippocampus but not into basa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced func

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein--infused rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Amyloid beta-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Amyloid beta peptide membrane perturbation is the basis for its biological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Smoking history and aging-associated cognitive decline: An event-related brain potential study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic systems and cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: Reversal by arecoline and differential effects of muscarinic and nicotinic antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic receptor activation facilitates GABAergic neurotransmission in the avian lateral spiriform nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Amyloid beta-peptide(25-35) changes [Ca2+] in hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine effects on the regulation of amyloid precursor protein splicing, neurotrophin and glucose transporter RNA levels in aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

beta-Amyloid peptide decreases membrane fluidity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Beta-amyloidosis in normal aging and transmitter signaling in human temporal lobe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic Stimulation of [3H]Acetylcholine Release from Mouse Cerebral Cortical Synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine inhibits amyloid formation by the beta-peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Aggregates of a beta-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: relation to Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Activation of LA-N-2 cell phospholipase D by amyloid beta protein (25-35).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

(-)Nicotine inhibits the activations of phospholipases A2 and D by amyloid beta peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Acetylcholine receptors: too many channels, too few functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Stimulation of phospholipase C activity by norepinephrine, t-ACPD and bombesin in LA-N-2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

A family of metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Relation between nicotine intake and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotinic receptors in the brain. Molecular biology, function, and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Basal forebrain lesions in monkeys disrupt attention but not learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Neurotoxicity of A beta amyloid protein in vitro is not altered by calcium channel blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Presynaptic nicotinic ACh receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine modulates the neurotoxic effect of beta-amyloid protein(25-35)) in hippocampal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Distributions of nicotinic acetylcholine receptor alpha7 and beta2 subunits on cultured hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Postnatal changes of nicotinic acetylcholine receptor alpha 2, alpha 3, alpha 4, alpha 7 and beta 2 subunits genes expression in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Free radical formation in autopsy samples of Alzheimer and control cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901108-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(00)01108-2

1 reference

6 July 2017

1 reference

PubMed ID

11230873